News

Morepen Laboratories has started production of the test batch of Russia's Sputnik V Covid-19 vaccine at its facility in Himachal Pradesh, Russian Direct Investment Fund (RDIF) and the domestic drug firm said in a statement. The first batch will be...

BioMed X, a leading independent research institute, announced the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany. The new program will explore the role of extrachromosomal DNA in cancer and it will complement the research...

Global contract development and manufacturing organisation (CDMO), Recipharm, has signed an MOU, along with His Majesty the King of Morocco, Mohammed VI, the Moroccan Government and a consortium of the country’s leading banks, that will see the company operate...

IT major Tech Mahindra said it has partnered with StaTwig, a Singapore and Hyderabad-based digital supply chain solution provider, to implement vaccine traceability platform "VaccineLedger" globally. The companies aim to roll-out a blockchain-based traceability solution for global vaccine supply chain...

GlaxoSmithKline plc and Alector announced a strategic global collaboration for the development and commercialisation of two clinical-stage, potential first-in-class monoclonal antibodies (AL001 and AL101) designed to elevate progranulin (PGRN) levels. PGRN is a key regulator of immune activity in...

Sosei Group Corporation, the world leader in GPCR-focused structure-based drug design and development, and InveniAI® LLC, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across drug discovery and development,...

Fujifilm has unveiled its plans to invest JPY90bn ($850m) in its subsidiary Fujifilm Diosynth Biotechnologies (FDB) to expand its capacity for biologics. FDB is a Contract Development and Manufacturing Organisation (CDMO) that develops and manufactures recombinant proteins, vaccines, monoclonal antibodies,...